Trademark: 87568745
Status Date
Tuesday, November 13, 2018
Registration Number
5604338
Registration Date
Tuesday, November 13, 2018
Filing Date
Tuesday, August 15, 2017
Published for Opposition
Tuesday, August 28, 2018
5 Pharmaceutical preparations, namely, chemiotherapeutical medicines and medicines that act on the endocrinal functions, hormones, and on metabolism for the treatment of prostate cancer, endometriosis, precocious puberty, breast cancer, in vitro fertilization, ovarian cancer, fibroma and polycystic ovarian cancer
The wording "PAMORELIN" has no meaning in a foreign language.
Nov 13, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Nov 13, 2018
Registered-Principal Register
Aug 28, 2018
Official Gazette Publication Confirmation E-Mailed
Aug 28, 2018
Published For Opposition
Aug 8, 2018
Notification Of Notice Of Publication E-Mailed
Jul 24, 2018
Approved For Pub - Principal Register
May 30, 2018
Teas/Email Correspondence Entered
May 30, 2018
Correspondence Received In Law Office
May 29, 2018
Assigned To Lie
May 21, 2018
Teas Response To Office Action Received
Nov 20, 2017
Notification Of Non-Final Action E-Mailed
Nov 20, 2017
Non-Final Action E-Mailed
Nov 20, 2017
Non-Final Action Written
Nov 17, 2017
Assigned To Examiner
Aug 21, 2017
New Application Office Supplied Data Entered
Aug 18, 2017
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
